pasireotide

FDA Drug Profile — Signifor LAR, Signifor

Drug Details

Generic Name
pasireotide
Brand Names
Signifor LAR, Signifor
Application Number
NDA203255
Sponsor
Synergy Health AST, LLC
NDC Codes
13
Dosage Forms
INJECTION, POWDER, FOR SUSPENSION, KIT, INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
PASIREOTIDE

Indications and Usage

1 INDICATIONS AND USAGE SIGNIFOR is a somatostatin analog indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative ( 1 ) 1.1 Cushing's Disease SIGNIFOR is indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.